Key Takeaways
- Rocket Lab finalized its at-the-market equity program, offloading approximately 6.7 million shares for roughly $474 million in gross capital.
- Additional collared forward agreements covering around 7.5 million shares could bring between $474 million and $642 million in proceeds.
- Capital will support expansion initiatives, possible M&A activity, and general operational needs.
- Citizens analyst Trevor Walsh elevated RKLB to Buy from Hold while maintaining an $85 price objective.
- Wall Street’s consensus price target of $86.77 suggests approximately 25.6% appreciation potential.
Rocket Lab wrapped up its $1 billion at-the-market equity program this Wednesday, securing approximately $474 million in gross capital. Shares responded with a roughly 5% advance.
The aerospace firm offloaded roughly 6.7 million shares via at-the-market mechanisms. Alongside this, the company structured collared forward agreements encompassing about 7.5 million shares.
These forward arrangements are expected to deliver minimum proceeds around $474 million, with a ceiling near $642 million. Settlement is scheduled for April 2028, though earlier resolution is possible.
The equity program originated on March 17, 2026, when Rocket Lab filed documentation to sell as much as $1 billion in equity. Wednesday’s announcement marks the program’s conclusion.
The company indicated proceeds will fuel expansion efforts, potentially including strategic acquisitions, along with covering working capital and general corporate requirements. No acquisition candidates were disclosed.
The share price advancement occurred amid broader market strength, which provided favorable conditions.
Wall Street Upgrades Drive Investor Confidence
Earlier in the week, Trevor Walsh from Citizens lifted his rating on RKLB to Buy from Hold. His $85 price objective remains unchanged, pointing to approximately 25% upside opportunity.
Walsh emphasized the current valuation as an attractive entry opportunity. He also highlighted the company’s strategic pivot toward defense contracts and space infrastructure services as drivers for improved profitability and revenue consistency.
The analyst referenced the upcoming SpaceX public offering — potentially commanding a $2 trillion valuation — as a sector catalyst that could redirect investor capital toward space industry players.
Sujeeva De Silva from Roth MKM maintained his Buy stance with a $90 target. De Silva emphasized the expanding order book and the company’s movement into satellite hardware manufacturing.
De Silva characterized Rocket Lab as “successfully diversifying into Space Systems,” extending beyond traditional launch services. The robust backlog signals substantial growth runway, in his view.
According to TipRanks data, RKLB carries a Moderate Buy consensus. This reflects 10 Buy recommendations and five Hold ratings issued during the past three months.
The consensus price objective among analysts stands at $86.77, indicating roughly 25.6% appreciation from present price levels.
Neutron Program Represents Critical Growth Driver
Beyond the capital infusion, Rocket Lab’s Neutron launch vehicle remains a focal point for investors. The 43-meter partially reusable rocket targets satellite deployment and cargo transport markets.
Critical hardware elements — including the proprietary “Hungry Hippo” payload fairing and primary thrust assembly — are prepared for final integration. Initial flight operations are projected for late 2026 or early 2027.
Gregory Pendy from Clear Street observed that Neutron opens access to larger market segments than the existing Electron platform while delivering enhanced per-mission economics. This positions it as a significant growth catalyst.
Rocket Lab shares have experienced considerable volatility throughout 2026, posting minimal net progress year-to-date. The Wall Street consensus target currently rests at $86.77.
